Superluminal Medicines, Inc.
Filings
2
Original notices
2
Amendments
0
Activity
Aug 26, 2025
through Sep 3, 2026
through Sep 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Latest available filing snapshot
- Reported offering amount
- $65,480,796
- Reported amount sold
- $65,480,796
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001989478-26-000001D · Sep 3, 2026 · BiotechnologyOffering: $65,480,796Sold: $65,480,796
-
0001989478-25-000001D · Aug 26, 2025 · BiotechnologyOffering: $5,000,000Sold: $5,000,000